vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and LINKBANCORP, Inc. (LNKB). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $46.0M, roughly 1.8× LINKBANCORP, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 6.4%, a 16.4% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 7.3%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $23.8M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 6.6%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.
FDMT vs LNKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $46.0M |
| Net Profit | $19.4M | $2.9M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | 8.5% |
| Net Margin | 22.8% | 6.4% |
| Revenue YoY | 8508900.0% | 7.3% |
| Net Profit YoY | 139.1% | -61.2% |
| EPS (diluted) | $0.43 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $46.0M | ||
| Q3 25 | $90.0K | $44.8M | ||
| Q2 25 | $15.0K | $42.3M | ||
| Q1 25 | $14.0K | $53.4M | ||
| Q4 24 | $1.0K | $42.9M | ||
| Q3 24 | $3.0K | $42.9M | ||
| Q2 24 | $5.0K | $41.3M | ||
| Q1 24 | $28.0K | $40.5M |
| Q4 25 | $19.4M | $2.9M | ||
| Q3 25 | $-56.9M | $7.8M | ||
| Q2 25 | $-54.7M | $7.4M | ||
| Q1 25 | $-48.0M | $15.3M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $-43.8M | $7.1M | ||
| Q2 24 | $-35.0M | $5.8M | ||
| Q1 24 | $-32.4M | $5.7M |
| Q4 25 | 17.3% | 8.5% | ||
| Q3 25 | -67983.3% | 22.3% | ||
| Q2 25 | -396373.3% | 22.4% | ||
| Q1 25 | -383007.1% | 36.0% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | -1704400.0% | 21.3% | ||
| Q2 24 | -849120.0% | 18.0% | ||
| Q1 24 | -136200.0% | 18.1% |
| Q4 25 | 22.8% | 6.4% | ||
| Q3 25 | -63195.6% | 17.5% | ||
| Q2 25 | -364386.7% | 17.5% | ||
| Q1 25 | -342657.1% | 28.7% | ||
| Q4 24 | — | 17.7% | ||
| Q3 24 | -1461433.3% | 16.5% | ||
| Q2 24 | -699060.0% | 14.1% | ||
| Q1 24 | -115717.9% | 14.1% |
| Q4 25 | $0.43 | $0.08 | ||
| Q3 25 | $-1.01 | $0.21 | ||
| Q2 25 | $-0.98 | $0.20 | ||
| Q1 25 | $-0.86 | $0.41 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | $-0.79 | $0.19 | ||
| Q2 24 | $-0.63 | $0.16 | ||
| Q1 24 | $-0.66 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $52.3M |
| Total DebtLower is stronger | — | $177.3M |
| Stockholders' EquityBook value | $505.7M | $306.4M |
| Total Assets | $566.7M | $3.1B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $52.3M | ||
| Q3 25 | $305.1M | $194.2M | ||
| Q2 25 | $293.2M | $155.1M | ||
| Q1 25 | $321.4M | $220.2M | ||
| Q4 24 | $424.9M | $166.1M | ||
| Q3 24 | $501.9M | $191.2M | ||
| Q2 24 | $541.9M | $181.7M | ||
| Q1 24 | $525.9M | $172.3M |
| Q4 25 | — | $177.3M | ||
| Q3 25 | — | $102.3M | ||
| Q2 25 | — | $102.3M | ||
| Q1 25 | — | $102.7M | ||
| Q4 24 | — | $112.5M | ||
| Q3 24 | — | $102.4M | ||
| Q2 24 | — | $102.3M | ||
| Q1 24 | — | $102.2M |
| Q4 25 | $505.7M | $306.4M | ||
| Q3 25 | $369.0M | $305.5M | ||
| Q2 25 | $420.9M | $298.0M | ||
| Q1 25 | $469.7M | $294.1M | ||
| Q4 24 | $510.6M | $280.2M | ||
| Q3 24 | $552.9M | $277.4M | ||
| Q2 24 | $588.3M | $271.4M | ||
| Q1 24 | $600.6M | $268.2M |
| Q4 25 | $566.7M | $3.1B | ||
| Q3 25 | $424.0M | $3.1B | ||
| Q2 25 | $473.6M | $2.9B | ||
| Q1 25 | $515.7M | $2.9B | ||
| Q4 24 | $560.4M | $2.9B | ||
| Q3 24 | $604.0M | $2.9B | ||
| Q2 24 | $620.1M | $2.9B | ||
| Q1 24 | $629.9M | $2.8B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.33× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 0.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $25.3M |
| Free Cash FlowOCF − Capex | $28.5M | $23.8M |
| FCF MarginFCF / Revenue | 33.5% | 51.7% |
| Capex IntensityCapex / Revenue | 0.1% | 3.2% |
| Cash ConversionOCF / Net Profit | 1.47× | 8.59× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $55.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $25.3M | ||
| Q3 25 | $-46.5M | $23.6M | ||
| Q2 25 | $-43.4M | $6.3M | ||
| Q1 25 | $-47.8M | $2.6M | ||
| Q4 24 | $-134.6M | $25.4M | ||
| Q3 24 | $-29.4M | $14.0M | ||
| Q2 24 | $-30.2M | $6.4M | ||
| Q1 24 | $-29.1M | $-771.0K |
| Q4 25 | $28.5M | $23.8M | ||
| Q3 25 | $-46.6M | $23.2M | ||
| Q2 25 | $-43.4M | $6.1M | ||
| Q1 25 | $-48.4M | $2.2M | ||
| Q4 24 | $-138.4M | $22.6M | ||
| Q3 24 | $-31.2M | $13.1M | ||
| Q2 24 | $-30.6M | $6.3M | ||
| Q1 24 | $-29.8M | $-1.2M |
| Q4 25 | 33.5% | 51.7% | ||
| Q3 25 | -51765.6% | 51.8% | ||
| Q2 25 | -289620.0% | 14.5% | ||
| Q1 25 | -345635.7% | 4.2% | ||
| Q4 24 | -13837100.0% | 52.6% | ||
| Q3 24 | -1038966.7% | 30.5% | ||
| Q2 24 | -611840.0% | 15.3% | ||
| Q1 24 | -106421.4% | -3.0% |
| Q4 25 | 0.1% | 3.2% | ||
| Q3 25 | 101.1% | 0.8% | ||
| Q2 25 | 440.0% | 0.4% | ||
| Q1 25 | 4507.1% | 0.7% | ||
| Q4 24 | 378600.0% | 6.7% | ||
| Q3 24 | 59266.7% | 2.1% | ||
| Q2 24 | 6980.0% | 0.1% | ||
| Q1 24 | 2535.7% | 1.1% |
| Q4 25 | 1.47× | 8.59× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | — | 3.35× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
